glp 1 indications The expanding benefits of GLP-1 medicines: Cell Reports Medicine Oral semaglutide (Rybelsus) is the

Preclinical studies have confirmed that GIPRGLP1R coagonists improve several hallmarks of metabolic syndrome, such as obesity, hyperglycemia, and dyslipidemia

Clinical Significance: The 2025 updates reaffirm that while HbA1c remains central, a one-number-fits-all strategy is outdated

Hansoh Pharma will receive an upfront payment of $112 million and is eligible to receive up to $1.9 billion in milestone payments associated with the development, regulatory approval and

People who stop taking GLP-1 drugs like Ozempic are finding that their hunger comes back -- with a vengeance.

The use of branded ingredients allows private label partners to leverage established research narratives, ingredient storytelling, and clinical positioning strategies in their marketing materials

Smart carb options